1333243-79-0

Basic information

• Product Name: C₃₂H₂₇FN₂O₆S₂
• Synonyms: C₃₂H₂₇FN₂O₆S₂
• CAS NO: 1333243-79-0
• Molecular Weight: 618.707
• Mol File: 1333243-79-0.mol

Chemical Properties

• CAS DataBase Reference: C₃₂H₂₇FN₂O₆S₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₂H₂₇FN₂O₆S₂(1333243-79-0)
• EPA Substance Registry System: C₃₂H₂₇FN₂O₆S₂(1333243-79-0)

Safety Data

• Hazardous Substances Data: 1333243-79-0(Hazardous Substances Data)

Upstream product

• 1333243-78-9 C₃₂H₂₅FN₂O₆S₂ 
• 1333244-29-3 2-(4-fluorophenyl)-5-(3-iodophenyl)-N-methyl-6-(N-methylmethylsulfonamido)benzofuran-3-carboxamide 
• 1333244-28-2 5-(3-aminophenyl)-2-(4-fluorophenyl)-N-methyl-6-(N-methylmethylsulfonamido)benzofuran-3-carboxamide 
• 1333244-27-1 2-(4-fluorophenyl)-N-methyl-6-(N-methylmethylsulfonamido)-5-(3-nitrophenyl)benzofuran-3-carboxamide 
• 1333243-55-2 5-(3-(benzo[b]thiophen-2-yl)phenyl)-2-(4-fluorophenyl)-N-methyl-6-(N-methylmethylsulfonamido)benzofuran-3-carboxamide 
• 1333225-19-6 5-bromo-2-(4-fluorophenyl)-6-(N-methylmethylsulfonamido)-1-benzofuran-3-carboxylic acid 
• 1333225-35-6 methyl 5-bromo-2-(4-fluorophenyl)-6-(N-methylmethylsulfonamido)benzofuran-3-carboxylate 
• 1333225-34-5 methyl 5-bromo-2-(4-fluorophenyl)-6-(methanesulfonamido)benzofuran-3-carboxylate 
• 1333225-33-4 methyl 6-amino-5-bromo-2-(4-fluorophenyl)benzofuran-3-carboxylate 
• 1333225-32-3 methyl 5-bromo-2-(4-fluorophenyl)-6-nitrobenzofuran-3-carboxylate 
• 1333225-31-2 methyl 5-bromo-2-(4-fluorophenyl)benzofuran-3-carboxylate 
• 1333225-30-1 methyl 2-(5-bromo-2-hydroxyphenyl)-3-(4-fluorophenyl)-3-oxopropanoate 
• 1333225-29-8 methyl 2-(5-bromo-2-(tert-butyldimethylsilyloxy)phenyl)-3-(4-fluorophenyl)-3-oxopropanoate 
• 1333225-28-7 methyl 2-(5-bromo-2-((tert-butyldimethylsilyl)oxy)-phenyl)acetate 

Relevant articles and documents

INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE

Compounds of formula (I) that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and /or viral production in a cell-based system. Wherein Z, R30, R40, R50 and R60 of compounds of formula (I) are herein defined as in the description.